Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
VNDA
Stock Latest News
Ratings
Vanda Pharmaceuticals: Promising Pipeline and Regulatory Progress Drive Buy Rating
7d ago
VNDA
Premium
The Fly
Vanda Pharmaceuticals announces submission of BLA to FDA for imsidolimab
8d ago
VNDA
Premium
Company Announcements
FDA Lifts Hold on Vanda’s Tradipitant Trials
18d ago
8K
VNDA
Premium
The Fly
FDA lifts partial clinical hold on Vanda Pharmaceuticals’ tradipitant
18d ago
VNDA
Premium
Ratings
Vanda Pharmaceuticals: Buy Rating Backed by Promising Drug Pipeline and Market Potential
22d ago
VNDA
Premium
Company Announcements
Vanda Pharmaceuticals Updates on Tradipitant FDA Review
24d ago
8K
VNDA
Premium
The Fly
Vanda Pharmaceuticals provides regulatory update on tradipitant
25d ago
VNDA
Premium
The Fly
Vanda Pharmaceuticals’ tradipitant shows positive results in nausea, vomiting
1M ago
VNDA
Premium
The Fly
AnaptysBio price target raised to $36 from $20 at Truist
1M ago
ANAB
VNDA
Premium
The Fly
Pinterest downgraded, Tractor Supply upgraded: Wall Street’s top analyst calls
2M ago
ADM
LMT
Premium
The Fly
Vanda Pharmaceuticals initiated with a Buy at B. Riley
2M ago
VNDA
Premium
Company Announcements
Vanda Pharmaceuticals’ Earnings Call: Growth Amid Challenges
2M ago
VNDA
Premium
Company Announcements
Vanda Pharmaceuticals Reports Strong Sales Growth and Pipeline Progress
2M ago
VNDA
Premium
The Fly
Vanda Pharmaceuticals reports Q3 EPS (38c), consensus (45c)
2M ago
VNDA
Premium
The Fly
Vanda Pharmaceuticals sees FY25 revenue $210M-$250M, consensus $224.84M
2M ago
VNDA
Premium
Company Announcements
Vanda Pharmaceuticals Advances with Promising Social Anxiety Disorder Treatment Study
2M ago
VNDA
Premium
Company Announcements
Vanda Pharmaceuticals Advances Dry Eye Treatment with VSJ-110 Study
2M ago
VNDA
Premium
Company Announcements
Vanda Pharmaceuticals Completes Key Bioequivalence Study for Schizophrenia and Bipolar Disorder Treatment
2M ago
VNDA
Premium
Pre-Earnings
VNDA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
VNDA
Premium
Ratings
Vanda’s FDA Agreement Boosts Buy Rating with Expedited Drug Reviews
3M ago
VNDA
Premium
Company Announcements
Vanda Pharmaceuticals Reaches Agreement with FDA
3M ago
8K
VNDA
Premium
The Fly
Vanda Pharmaceuticals, FDA agree to resolve disputes on Hetlioz and tradipitant
3M ago
VNDA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
